Last update 09 Feb 2026

Compound 9e(Universitario de Valencia)

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
5-HT2A receptor x D2 receptor x D3 receptor
Action
antagonists, agonists, modulators
Mechanism
5-HT2A receptor antagonists(Serotonin 2a (5-HT2a) receptor antagonists), D2 receptor agonists(Dopamine D2 receptor agonists), D3 receptor modulators(Dopamine D3 receptor modulators)
Therapeutic Areas
Nervous System Diseases
Active Indication
Schizophrenia
Inactive Indication-
Originator Organization
University of ValenciaUniversity of ValenciaHospital General Universitari de ValènciaHospital General Universitari de València
Active Organization
Hospital General Universitari de ValènciaHospital General Universitari de ValènciaUniversity of ValenciaUniversity of Valencia
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with Compound 9e(Universitario de Valencia)
Login to view more data
100 Translational Medicine associated with Compound 9e(Universitario de Valencia)
Login to view more data
100 Patents (Medical) associated with Compound 9e(Universitario de Valencia)
Login to view more data
100 Deals associated with Compound 9e(Universitario de Valencia)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
SchizophreniaPreclinical
Spain
Hospital General Universitari de ValènciaHospital General Universitari de València
01 Nov 2025
SchizophreniaPreclinical
Spain
University of ValenciaUniversity of Valencia
01 Nov 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free